Cargando…

Signal Transduction Profiling of Angiotensin II Type 1 Receptor With Mutations Associated to Atrial Fibrillation in Humans

The AT1 receptor (AT1R) has a major role in the Renin-Angiotensin System, being involved in several physiological events including blood pressure control and electrolyte balance. The AT1R is a member of the G protein coupled receptors (GPCR) family, classically known to couple G(αq) and engage β-arr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Simões, Sarah C., Balico-Silva, André L., Parreiras-e-Silva, Lucas T., Bitencourt, André L. B., Bouvier, Michel, Costa-Neto, Claudio M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7786401/ https://www.ncbi.nlm.nih.gov/pubmed/33424609 http://dx.doi.org/10.3389/fphar.2020.600132

Ejemplares similares

Comparative analyses of downstream signal transduction targets modulated after activation of the AT(1) receptor by two β-arrestin-biased agonists
por: Santos, Geisa A., et al.
Publicado: (2015)

Pharmacological Characterization of 5-Substituted 1-[(2,3-dihydro-1-benzofuran-2-yl)methyl]piperazines: Novel Antagonists for the Histamine H(3) and H(4) Receptors with Anti-inflammatory Potential
por: Corrêa, Michelle F., et al.
Publicado: (2017)

Hydrogen Sulfide Ameliorates Angiotensin II-Induced Atrial Fibrosis Progression to Atrial Fibrillation Through Inhibition of the Warburg Effect and Endoplasmic Reticulum Stress
por: Hu, Heng-Jing, et al.
Publicado: (2021)

Phosphatidylethanolamine aggravates Angiotensin II-induced atrial fibrosis by triggering ferroptosis in mice
por: Huang, Fangze, et al.
Publicado: (2023)

Evaluation of Functional Selectivity of Haloperidol, Clozapine, and LASSBio-579, an Experimental Compound With Antipsychotic-Like Actions in Rodents, at G Protein and Arrestin Signaling Downstream of the Dopamine D(2) Receptor
por: Silva, Rafaela R., et al.
Publicado: (2019)

Cannabinoid receptor agonist attenuates angiotensin II–induced enlargement and mitochondrial dysfunction in rat atrial cardiomyocytes
por: Altieri, Danielle I., et al.
Publicado: (2023)

Regional and temporal progression of atrial remodeling in angiotensin II mediated atrial fibrillation
por: Jansen, Hailey J., et al.
Publicado: (2022)

An instrument to measure atrial fibrillation knowledge in Chinese patients: validation of the Jessa Atrial fibrillation Knowledge Questionnaire
por: Chang, Sijie, et al.
Publicado: (2023)

Angiotensin II receptor blockers in the prevention of complications from atrial fibrillation
por: Naccarelli, Gerald V, et al.
Publicado: (2009)

Isoproterenol Increases Left Atrial Fibrosis and Susceptibility to Atrial Fibrillation by Inducing Atrial Ischemic Infarction in Rats
por: Ma, Shiyu, et al.
Publicado: (2020)

Epoxyeicosatrienoic acid analog attenuates angiotensin II hypertension and kidney injury
por: Hye Khan, Md. Abdul, et al.
Publicado: (2014)

Honokiol Inhibits Atrial Metabolic Remodeling in Atrial Fibrillation Through Sirt3 Pathway
por: Liu, Guang Zhong, et al.
Publicado: (2022)

Calcium dysregulation in atrial fibrillation: the role of CaMKII
por: Heijman, Jordi, et al.
Publicado: (2014)

The Antimalarial Chloroquine Reduces the Burden of Persistent Atrial Fibrillation
por: Tobón, Catalina, et al.
Publicado: (2019)

Endogenous CCN5 Participates in Angiotensin II/TGF-β(1) Networking of Cardiac Fibrosis in High Angiotensin II-Induced Hypertensive Heart Failure
por: Huang, Anan, et al.
Publicado: (2020)

Angiotensin II-Induced Signal Transduction Mechanisms for Cardiac Hypertrophy
por: Bhullar, Sukhwinder K., et al.
Publicado: (2022)

Neohesperidin Protects Angiotensin II-Induced Hypertension and Vascular Remodeling
por: Zhang, Jingsi, et al.
Publicado: (2022)

Sacubitril/Valsartan Improves Left Atrial and Left Atrial Appendage Function in Patients With Atrial Fibrillation and in Pressure Overload-Induced Mice
por: Suo, Ya, et al.
Publicado: (2019)

Initiation and Persistence with Warfarin Therapy in Atrial Fibrillation According to Ethnicity
por: Hansen, Carolina Malta, et al.
Publicado: (2012)

Anticancer Therapy-Induced Atrial Fibrillation: Electrophysiology and Related Mechanisms
por: Yang, Xinyu, et al.
Publicado: (2018)

Factors Associated With Edoxaban Concentration Among Patients With Atrial Fibrillation
por: Lin, Shin-Yi, et al.
Publicado: (2021)

Farrerol prevents Angiotensin II-induced cardiac remodeling in vivo and in vitro
por: He, Jian, et al.
Publicado: (2023)

Angiotensin Receptors Heterodimerization and Trafficking: How Much Do They Influence Their Biological Function?
por: Rukavina Mikusic, Natalia L., et al.
Publicado: (2020)

Digoxin and Amiodarone on the Risk of Ischemic Stroke in Atrial Fibrillation: An Observational Study
por: Lai, Kuan-Cheng, et al.
Publicado: (2018)

Erratum on: Epoxyeicosatrienoic acid analog attenuates angiotensin II hypertension and kidney injury
Publicado: (2014)

Angiotensin II-Regulated Autophagy Is Required for Vascular Smooth Muscle Cell Hypertrophy
por: Mondaca-Ruff, David, et al.
Publicado: (2019)

An Insight on Multicentric Signaling of Angiotensin II in Cardiovascular system: A Recent Update
por: Verma, Kanika, et al.
Publicado: (2021)

The Angiotensin-(1-7)/Mas Axis Counteracts Angiotensin II-Dependent and -Independent Pro-inflammatory Signaling in Human Vascular Smooth Muscle Cells
por: Villalobos, Laura A., et al.
Publicado: (2016)

Angiotensin II Receptor Blockers but Not Angiotensin-Converting Enzyme Inhibitors Are Associated With a Reduced Risk of Acute Kidney Injury After Major Surgery
por: Yang, Shao-Yu, et al.
Publicado: (2021)

Effectiveness and Safety of Oral Anticoagulants in Older Patients With Atrial Fibrillation: A Systematic Review and Meta-Analysis
por: Grymonprez, Maxim, et al.
Publicado: (2020)

Early pharmacological inhibition of angiotensin-I converting enzyme activity induces obesity in adulthood
por: de Picoli Souza, Kely, et al.
Publicado: (2015)

Pharmacological Inhibition of Serine Proteases to Reduce Cardiac Inflammation and Fibrosis in Atrial Fibrillation
por: Coppini, Raffaele, et al.
Publicado: (2019)

Comparative Effectiveness and Safety of Low-Dose Oral Anticoagulants in Patients With Atrial Fibrillation
por: Perreault, Sylvie, et al.
Publicado: (2022)

Cardiac-specific knockdown of Bhlhe40 attenuates angiotensin II (Ang II)-Induced atrial fibrillation in mice
por: Ren, Kai-Wen, et al.
Publicado: (2022)

Potassium Intake Prevents the Induction of the Renin-Angiotensin System and Increases Medullary ACE2 and COX-2 in the Kidneys of Angiotensin II-Dependent Hypertensive Rats
por: Gonzalez, Alexis A., et al.
Publicado: (2019)

Effects of Angiotensin-II Receptor Blocker on Inhibition of Thrombogenicity in a Canine Atrial Fibrillation Model
por: Choi, Jong-Il, et al.
Publicado: (2016)

Current Drug Treatment Strategies for Atrial Fibrillation and TASK-1 Inhibition as an Emerging Novel Therapy Option
por: Kraft, Manuel, et al.
Publicado: (2021)

Executive Summary of the II Brazilian Guidelines for Atrial Fibrillation
por: de Magalhães, Luiz Pereira, et al.
Publicado: (2016)

Blocking VCAM-1 Prevents Angiotensin II-Induced Hypertension and Vascular Remodeling in Mice
por: Yin, Liangqingqing, et al.
Publicado: (2022)

Oral Anticoagulants Initiation in Patients with Atrial Fibrillation: Real-World Data from a Population-Based Cohort
por: Rodríguez-Bernal, Clara L., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_0ns5rqvv99etvhevirveorkkjs